Lersivirine, CAS [[473921-12-9]]

Produktübersicht

• Artikelname: Lersivirine, CAS [[473921-12-9]]
• Artikelnummer: BYT-ORB1299580
• Hersteller Artikelnummer: orb1299580
• Alternativnummer: BYT-ORB1299580-5,BYT-ORB1299580-1,BYT-ORB1299580-10,BYT-ORB1299580-25,BYT-ORB1299580-50,BYT-ORB1299580-100,BYT-ORB1299580-200
• Hersteller: Biorbyt
• Kategorie: Biochemikalien
• Alternative Synonym: NNRTI, NNRTI-resistant, inhibit, Inhibitor, non-nucleoside reverse transcription, Lersivirine, Lersivirine(UK 453061), HIV, HIVProtease, HIV virus, HIV Protease, Human immunodeficiency virus, resistant strain, ReverseTranscriptase, Reverse Transcriptase, UK 453061, UK453061, UK-453061

Produktbeschreibung

Lersivirine (UK-453061) is a next-generation NNRTI developed for the treatment of HIV-1 infection. It has demonstrated potent antiviral activity in vitro and has been evaluated in clinical trials for its efficacy against both wild-type and drug-resistant virus strains.

Produkteigenschaften

• Molekulargewicht: 310.35
• Reinheit: 99.26% (May vary between batches)
• CAS Nummer: [473921-12-9]
• Formel: C17H18N4O2
• Target-Kategorie: Reverse Transcriptase,HIV Protease

Anwendungsbeschreibung

• Anwendungsbeschreibung: Solubility: DMSO:50 mg/mL (161.11 mM),10% DMSO+40% PEG300+5% Tween 80+45% Saline:2.5 mg/mL (8.06 mM)